Trials / Conditions / Autosomal Recessive Hypophosphatemic Rickets
Autosomal Recessive Hypophosphatemic Rickets
7 registered clinical trials studyying Autosomal Recessive Hypophosphatemic Rickets — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | ENERGY 2: Evaluation of the Efficacy and Safety of INZ-701 in Infants With ENPP1 Deficiency NCT07473973 | Inozyme Pharma | Phase 3 |
| Withdrawn | The ENABLE Study: Safety and Efficacy Study of INZ-701 in Patients With ENPP1 Deficiency NCT06739980 | Inozyme Pharma | Phase 2 |
| Active Not Recruiting | The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency NCT06046820 | Inozyme Pharma | Phase 3 |
| Recruiting | The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 D NCT05734196 | Inozyme Pharma | Phase 1 |
| Completed | Natural History Study of ENPP1 Deficiency and the Early-onset Form of ABCC6 Deficiency NCT05050669 | Inozyme Pharma | — |
| Completed | Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ENPP1 Deficiency NCT04686175 | Inozyme Pharma | Phase 1 / Phase 2 |
| Unknown | Natural History of GACI With or Without ARHR2 or PXE NCT03758534 | Universität Münster | — |